Trials that use: P-values
New to this method? Read the tutorial →
10,201 results
- Absorption Comparison on Equivalency Value of Genepro Gen2: Complete Statistical AnalysisIndependent statistical analysis of Absorption Comparison on Equivalency Value of Genepro Gen2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02919657).
- Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites: Complete Statistical AnalysisIndependent statistical analysis of Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease: Complete Statistical AnalysisIndependent statistical analysis of Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users: Complete Statistical AnalysisIndependent statistical analysis of Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ABY-029Independent statistical analysis of A Microdose Evaluation Study of ABY-029 in Recurrent Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02901925).
- AC-170Independent statistical analysis of Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- AC105Independent statistical analysis of AC105 in Patients With Acute Traumatic Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01750684).
- Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention: Complete Statistical AnalysisIndependent statistical analysis of Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00519779).
- Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Acamprosate to Reduce Symptoms of Alcohol Withdrawal: Complete Statistical AnalysisIndependent statistical analysis of Acamprosate to Reduce Symptoms of Alcohol Withdrawal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00106106).
- Acamprosate vs. Placebo in Bipolar Alcoholics: Complete Statistical AnalysisIndependent statistical analysis of Acamprosate vs. Placebo in Bipolar Alcoholics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00466661).
- ACCELERATEComplete statistical analysis of ACCELERATE (NCT01687998), a randomized phase 3 study of evacetrapib versus placebo in high-risk vascular disease, including trial design, composite cardiovascular endpoints, Cox modeling, ANOVA, confidence intervals, p-values, and…
- Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04058249).
- Accelerated Tooth Movement With AcceleDent® and Aligners – a Pilot Project: Complete Statistical AnalysisIndependent statistical analysis of Accelerated Tooth Movement With AcceleDent® and Aligners - a Pilot Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Accelerating Word Learning in Children With Language Impairment: Complete Statistical AnalysisIndependent statistical analysis of Accelerating Word Learning in Children With Language Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01829360).
- Accent CardiacIndependent statistical analysis of Accent Cardiac MRI Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02041702).
- Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03661840).
- ACCESSIndependent statistical analysis of ACCESS (Access for Cancer Caregivers for Education and Support for Shared Decision Making): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ACCESSIndependent statistical analysis of Adductor Canal Catheter Effectiveness and Safety Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04639128).
- ACCESS IIndependent statistical analysis of Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ACCOASTIndependent statistical analysis of A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ACCORDION-1Independent statistical analysis of Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection: primary endpoint results, effect…
- Accupressure of P6 to Reduce Nausea During Cesarean Section: Complete Statistical AnalysisIndependent statistical analysis of Accupressure of P6 to Reduce Nausea During Cesarean Section: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04799587).
- Accuracy of Self-estimation of Blood Alcohol Concentration Compared to Object Values: Complete Statistical AnalysisIndependent statistical analysis of Accuracy of Self-estimation of Blood Alcohol Concentration Compared to Object Values: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Accuracy of the New Barrett TAL Formula With the Argos Measurements: A Multicenter Prospective Study: Complete Statistical AnalysisIndependent statistical analysis of Accuracy of the New Barrett TAL Formula With the Argos Measurements: A Multicenter Prospective Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ACCURATEIndependent statistical analysis of A Safety and Effectiveness Trial of Spinal Cord Stimulation of the Dorsal Root Ganglion for Chronic Lower Limb Pain: primary endpoint results, effect estimate with confidence interval, sample-size…
- ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients: Complete Statistical AnalysisIndependent statistical analysis of ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01867047).
- ACESIndependent statistical analysis of ASPIRE Cognitive Enhancement Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02657954).
- Acetaminophen (APAP) +/- Oxycodone: Complete Statistical AnalysisIndependent statistical analysis of Acetaminophen (APAP) +/- Oxycodone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04122443).
- Acetaminophen Before Vaccines for Infants Study (AVIS): Complete Statistical AnalysisIndependent statistical analysis of Acetaminophen Before Vaccines for Infants Study (AVIS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00325819).
- Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm: Complete Statistical AnalysisIndependent statistical analysis of Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00585559).
- Acetazolamide Efficacy in Ataxia in PMM2-CDG: Complete Statistical AnalysisIndependent statistical analysis of Acetazolamide Efficacy in Ataxia in PMM2-CDG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04679389).
- Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ACHIEVEIndependent statistical analysis of Albumin for Intracerebral Hemorrhage Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00990509).
- ACHIEVEIndependent statistical analysis of Randomized Trial Of Achieving Healthy Lifestyles In Psych Rehabilitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00902694).
- ACHIEVE IComplete statistical analysis of ACHIEVE I, a randomized, double-blind phase 3 trial of oral ubrogepant for the acute treatment of migraine with or without aura, including endpoint definitions, logistic regression, odds ratios,…
- ACHIEVE-HIFUIndependent statistical analysis of ACHIEVE Hearing Intervention Follow-Up Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05070429).
- ACHIEVE2Independent statistical analysis of Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ACLIndependent statistical analysis of Ocular Adaptation and Visual Performance for Accommodative Contact Lens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02923232).
- ACOSOG Z1071Independent statistical analysis of ACOSOG Z1071, a phase 2 diagnostic trial evaluating sentinel lymph node surgery after chemotherapy in women with stage II, stage IIIA, or stage IIIB breast cancer.
- AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study: Complete Statistical AnalysisIndependent statistical analysis of AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04126187).
- ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises: Complete Statistical AnalysisIndependent statistical analysis of ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ACT IIndependent statistical analysis of Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I): primary endpoint results,…
- ACT-IPIndependent statistical analysis of Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01981356).
- ACTH Gel Therapy in Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of ACTH Gel Therapy in Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02030028).
- ACTHARIndependent statistical analysis of Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses: primary endpoint results, effect estimate with confidence interval, sample-size…
- Acthar Gel for Active Systemic Lupus Erythematosus (SLE): Complete Statistical AnalysisIndependent statistical analysis of Acthar Gel for Active Systemic Lupus Erythematosus (SLE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02953821).
- Actigraphic Analysis of Treatment Response: Complete Statistical AnalysisIndependent statistical analysis of Actigraphic Analysis of Treatment Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00723580).
- ACTIONIndependent statistical analysis of Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…